Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Unknown 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 11Myeloid 7Gynecologic 7Other hematologic neoplasm 6Lymphoid 6Thoracic 5Plasma cell 5Head & Neck 5Genitourinary 5Gastrointestinal 4Classical hematology 4Other 3Sarcoma 2CNS 2Other neoplasm 1NET 1Endocrine 1Dermatologic 1

Conditions

Brain Neoplasms 2313Glioblastoma 2016Glioma 1402Central Nervous System Neoplasms 692Astrocytoma 668Neuroblastoma 647Gliosarcoma 480Oligodendroglioma 405Neoplasms 405Breast Neoplasms 327Medulloblastoma 307Carcinoma, Non-Small-Cell Lung 256Meningioma 229Recurrence 224Sarcoma 215Melanoma 207Neoplasm Metastasis 202Ependymoma 200Lung Neoplasms 199Neurofibromatosis 1 169Lymphoma 162Meningeal Carcinomatosis 138Osteosarcoma 135Ovarian Neoplasms 132Wilms Tumor 123Precursor Cell Lymphoblastic Leukemia-Lymphoma 123Head and Neck Neoplasms 117Lymphoma, Non-Hodgkin 116Diffuse Intrinsic Pontine Glioma 113Rhabdomyosarcoma 107

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Hypersensitivity × CNS × Clear all
NCT04700748 2021-01-08

Diffusion-weighted MRI to Predict Treatment Response in Stereotactic Radiotherapy of Central Nervous System (CNS) Metastases

Lund University Hospital

Phase NA Unknown
150 enrolled
CNS

Brain Neoplasms, Hypersensitivity

NCT03739333 2020-02-13

TIGRE

Hospices Civils de Lyon

Phase NA Unknown
40 enrolled
CNS

Glioblastoma, Hypersensitivity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡